Siemens Healthineers, a healthcare company in Germany, has expected its business to grow by 5 to 8 per cent from the next year, the firm said on Monday.
In the fourth quarter, the German company lost its sales revenue by almost 2 per cent. Meanwhile, its operating gain plummetted to 564.22 million pounds, which is 626 million euros, a massive loss of 20 per cent.
The costs of its diagnostic unit rose for creating a kit (rapid antigen test) for testing the coronavirus infection in patients.
Notably, the analysts deployed by the company had expected 644 million euros (July-September) sans taxation and interest. It had earned 783 million euros the year before during the same period. However, it fell flat.
The adjusted EBIT of Healthineers fell to 2.23 billion euros, losing a whopping 10 per cent. The last year revenue of the company was 14.5 billion euros.